MTOR and chronic myelogenous leukemia, BCR-ABL1 positive: In CML cells treated with BEZ235, PI3K/Akt/mTOR activity and the levels of the antiapoptotic protein Bcl-2 decreased, while the levels of the proapoptotic protein Bax increased [103,109].